Abnormality Clinical Trials

37 recruitingLast updated: May 11, 2026

There are 37 actively recruiting abnormality clinical trials across 22 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4. Top locations include Philadelphia, Pennsylvania, United States, Milan, Italy, Antwerp, Wilrijk, Belgium. Updated daily from ClinicalTrials.gov.


Abnormality Trials at a Glance

37 actively recruiting trials for abnormality are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Philadelphia, Milan, and Antwerp. Lead sponsors running abnormality studies include Abbott Medical Devices, Abramson Cancer Center at Penn Medicine, and ASST Fatebenefratelli Sacco.

Browse abnormality trials by phase

Treatments under study

About Abnormality Clinical Trials

Looking for clinical trials for Abnormality? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Abnormality trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Abnormality clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 37 trials

Recruiting

Scottish Advanced Fetal Research Study

Life StyleHumanFetal Development+1 more
University of Aberdeen1,200 enrolled1 locationNCT04613583
Recruiting
Phase 1Phase 2

A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

Noise-induced hearing lossHearing LossHearing Disorders+22 more
University of Colorado, Denver344 enrolled1 locationNCT07304024
Recruiting
Not Applicable

Functional Outcomes in CondUction System Pacing and Right Ventricular Synchrony (FOCUS-Right)

Left Branch Bundle BlockRV - Right Ventricular Abnormality
Virginia Commonwealth University20 enrolled1 locationNCT06601322
Recruiting

Valved Graft PMCF Study

Aortic Valve DiseaseAortic DissectionAscending Aorta Abnormality
Abbott Medical Devices260 enrolled25 locationsNCT04754217
Recruiting
Phase 2

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+21 more
Masonic Cancer Center, University of Minnesota70 enrolled1 locationNCT05735717
Recruiting
Phase 1

FAPI-74 PET/CT in Adults With Fibrosis

Fibrosis (Morphologic Abnormality)
Abramson Cancer Center at Penn Medicine45 enrolled1 locationNCT06413355
Recruiting

Performance Evaluation of Dream OCT: AP Study

Glaucoma PatientsRetina PatientsEyes With Corneal Abnormality+1 more
Intalight, Inc120 enrolled1 locationNCT07355491
Recruiting
Not Applicable

A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)

Breast CancerBreast NeoplasmsEarly Breast Cancer+5 more
Vasileios Kalles15 enrolled1 locationNCT07292246
Recruiting
Not Applicable

A Study to Evaluate the Safety and Performance of a Vestibular Implant in Adults to Provide Balance Restoration

VestibulopathyModerate to Severe Hearing LossNormal Hearing+2 more
Cochlear18 enrolled3 locationsNCT06805175
Recruiting

The Diagnostic Observatory: Combating Diagnostic Wandering and Impasse Within the AnDDI-Rares Network

Developmental Abnormality
Centre Hospitalier Universitaire Dijon1,280 enrolled1 locationNCT05448326
Recruiting
Not Applicable

Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy

Alzheimer DiseaseCognitive AbnormalityAlzheimer Dementia+2 more
Covenant Health, US30 enrolled6 locationsNCT07222280
Recruiting

Turkish Version of the BRIEF-Hammersmith Infant Neurological Examination (HINE)

PediatricsNeurodevelopment OutcomeNeurological Abnormality
Kahramanmaras Sutcu Imam University120 enrolled1 locationNCT07182474
Recruiting
Not Applicable

Interventions in Mathematics and Cognitive Skills

Cognitive ChangeCognitive DysfunctionDecision Making+25 more
Stanford University180 enrolled1 locationNCT05201534
Recruiting
Phase 2

Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

C3 GlomerulopathyDense Deposit DiseaseMembranoproliferative Glomerulonephritis+2 more
Region Skane30 enrolled4 locationsNCT04183101
Recruiting
Not Applicable

Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia

Heart FailureRadiotherapy; ComplicationsVentricular Tachycardia+1 more
Barts & The London NHS Trust6 enrolled1 locationNCT05696522
Recruiting
Phase 4

Oxytocin and Fetal Heart Rate Changes

Fetal Heart Rate or Rhythm Abnormality Affecting FetusFetal Bradycardia Complicating Labor and DeliveryFetal Bradycardia During Labor
Unyime Ituk730 enrolled2 locationsNCT03232918
Recruiting

Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil

Chemotherapeutic ToxicityMinimal Residual DiseaseGene Abnormality+1 more
Instituto do Cancer do Estado de São Paulo180 enrolled1 locationNCT05959720
Recruiting
Not Applicable

Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease

Disc DegenerationDisc DiseaseNeurological Abnormality+2 more
Zetagen Therapeutics, Inc10 enrolled2 locationsNCT05971329
Recruiting

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

LymphomaGene Abnormality
Henan Cancer Hospital200 enrolled1 locationNCT04263935
Recruiting

Development of Motility and Cognition in Infants

developmental delayNeurodevelopmental DisordersDevelopment, Infant+3 more
Helsinki University Central Hospital250 enrolled1 locationNCT05527080